
1. General Information
Venlaf ER 37.5 mg Tablets contain venlafaxine, an antidepressant belonging to the serotonin-norepinephrine reuptake inhibitor (SNRI) class. Venlafaxine is a prescription medicine primarily used in the management of depression and certain anxiety-related disorders. It works by increasing the availability of serotonin and norepinephrine, two neurotransmitters involved in mood regulation.
Venlaf ER 37.5 mg is an extended-release/prolonged-release formulation, designed to provide gradual release of the active ingredient. It should be used only according to the prescription and guidance of a qualified healthcare professional.
Exporter: Phoenix Exim
Location: Nagpur, India
Export Markets: USA, UK, Australia, Singapore, Canada, South Korea and UAE
2. Product Information
Product Name: Venlaf ER 37.5 mg Tablets
Active Ingredient: Venlafaxine
Strength: 37.5 mg
Medicine Class: SNRI antidepressant
Dosage Form: Extended-release tablet
Route: Oral
Prescription Status: Prescription medicine
Primary therapeutic area: Depression and anxiety-related disorders
Venlafaxine extended-release tablets are available in several strengths, including 37.5 mg, 75 mg, 150 mg and 225 mg, depending on the manufacturer and market.
3. Uses of Venlaf ER 37.5 mg
Venlafaxine is prescribed for conditions such as:
Major depressive disorder
Social anxiety disorder
Generalized anxiety disorder, depending on the specific product and local approval
Panic disorder, depending on the formulation and prescribing guidelines
The 37.5 mg strength may be used as a starting or introductory dose in certain treatment situations, with the dose subsequently adjusted by the physician when appropriate. The approved uses and dosing recommendations can vary between countries and formulations.
4. Benefits of This Medicine
When appropriately prescribed, Venlaf ER may help:
Improve symptoms associated with depression
Reduce excessive anxiety and worry
Improve mood and emotional well-being
Help reduce symptoms associated with certain anxiety disorders
Support improved daily functioning when depression or anxiety is adequately controlled
The therapeutic response may take time, and patients should continue treatment according to their doctor's instructions rather than changing the dose themselves.
5. Side Effects of Venlaf ER 37.5 mg
Like other prescription antidepressants, venlafaxine can cause side effects. Not everyone experiences them, and some may become less noticeable as the body adjusts to treatment.
Possible side effects include:
Nausea
Headache
Dizziness
Drowsiness
Dry mouth
Constipation
Sweating
Insomnia or sleep disturbances
Vomiting
Diarrhea
Reduced appetite
Sexual dysfunction
Changes in blood pressure
Increased heart rate or palpitations
Venlafaxine can also cause clinically important adverse effects, including serotonin syndrome, increased blood pressure, abnormal bleeding, withdrawal symptoms after abrupt discontinuation, and activation of mania/hypomania in susceptible individuals.
6. Common Side Effects
Commonly reported effects may include:
Nausea
Headache
Dizziness
Drowsiness
Dry mouth
Constipation
Sweating
Difficulty sleeping
Reduced appetite
Sexual side effects
Vomiting or diarrhea
Increased nervousness or restlessness
If side effects are persistent, severe or troublesome, the patient should consult their doctor or pharmacist.
7. How to Use Venlaf ER 37.5 mg
Take Venlaf ER exactly as prescribed by your doctor.
General administration guidance for extended-release venlafaxine includes:
Take it at approximately the same time each day.
Extended-release formulations are generally taken once daily.
Take the medicine with food.
Swallow the tablet whole with water if the product instructions specify that it must not be crushed, chewed or dissolved.
Do not increase or decrease the dose without medical advice.
If you miss a dose, follow the instructions provided by your doctor or product leaflet; do not take a double dose to compensate.
Do not stop venlafaxine suddenly. The dose generally needs to be reduced gradually under medical supervision to reduce withdrawal/discontinuation symptoms.
The appropriate dose depends on the patient's condition, response to treatment, other medicines and kidney/liver function.
8. How Venlaf ER Works
Venlafaxine is an SNRI (serotonin-norepinephrine reuptake inhibitor).
It works primarily by reducing the reuptake of serotonin and norepinephrine in the brain. This increases the availability of these neurotransmitters in the nervous system and may help regulate mood, anxiety and related symptoms.
Because it is an extended-release formulation, the medicine is designed to release venlafaxine gradually rather than all at once.
9. Safety Advice for Venlaf ER 37.5 mg
Use only under the supervision of a qualified healthcare professional.
Do not take venlafaxine with an MAOI or within the medically specified interval after MAOI treatment because of the risk of serious interactions.
Inform your doctor about all prescription medicines, OTC medicines and supplements you use.
Tell your doctor if you have high blood pressure, heart problems, seizures, glaucoma, liver or kidney problems, or a history of bipolar disorder.
Blood pressure may need to be monitored during treatment.
Combining venlafaxine with other serotonergic medicines can increase the risk of serotonin syndrome.
Venlafaxine may increase bleeding risk, particularly when combined with medicines such as NSAIDs, aspirin or other medicines affecting blood clotting.
Avoid driving or operating machinery if the medicine causes dizziness or drowsiness.
Do not discontinue treatment abruptly; gradual dose reduction is generally recommended.
Antidepressants carry an important warning regarding suicidal thoughts and behaviors, particularly in children, adolescents and young adults. Any significant worsening of mood or suicidal thoughts requires prompt medical attention.
Seek urgent medical assistance for symptoms such as severe allergic reaction, severe agitation with fever and muscle rigidity, seizures, chest pain, severe confusion or other serious unexpected symptoms.
10. Frequently Asked Questions (FAQs)
Q1. What is Venlaf ER 37.5 mg?
Venlaf ER 37.5 mg is an extended-release formulation containing venlafaxine, an SNRI antidepressant used for depression and certain anxiety-related disorders.
Q2. Is Venlaf ER 37.5 mg a prescription medicine?
Yes. Venlafaxine is a prescription medicine and should be used according to a healthcare professional's instructions.
Q3. What is Venlaf ER 37.5 mg used for?
Depending on the specific formulation and local approval, venlafaxine may be prescribed for depression and certain anxiety disorders.
Q4. How long does Venlaf ER take to work?
The response varies between individuals. Some symptoms may improve before the full antidepressant effect develops. Continue treatment as prescribed and discuss progress with your doctor.
Q5. Can I stop Venlaf ER suddenly?
No. Venlafaxine should generally not be stopped abruptly because discontinuation symptoms can occur. A doctor can advise on gradual dose reduction.
Q6. Can Venlaf ER cause sleepiness?
Yes. Drowsiness or dizziness can occur. Until you know how the medicine affects you, use caution with driving or machinery.
Q7. Can Venlaf ER increase blood pressure?
Venlafaxine can increase blood pressure in some patients, so monitoring may be recommended during treatment.
Q8. Can Venlaf ER be taken with other antidepressants?
Not without medical supervision. Certain combinations can increase the risk of serotonin syndrome or other serious interactions.
Q9. Can I take a double dose if I miss one?
No. Follow the missed-dose instructions in your product leaflet or from your healthcare professional, and do not take an extra dose unless specifically instructed.
Q10. Who should not use Venlaf ER?
People with certain allergies or contraindications, including those taking specific MAOI medicines, may need to avoid venlafaxine. A doctor should review the patient's medical history and current medicines before treatment.
11. Substitute for Venlaf ER 37.5 mg
A substitute should not be selected solely on the basis of the strength. Depending on the patient's condition and the formulation, a healthcare professional may consider another product containing venlafaxine or another antidepressant from the SNRI/other antidepressant classes.
Possible alternatives may include:
Venlafaxine extended-release products from other manufacturers
Venlafaxine immediate-release formulations, where clinically appropriate
Desvenlafaxine, where appropriate
Other antidepressants selected by the physician according to the patient's diagnosis
Important: Extended-release and immediate-release venlafaxine products are not automatically interchangeable. The choice of substitute, strength and dosage schedule should be confirmed by a doctor or pharmacist.
12. SEO & B2B Keywords
Venlaf ER 37.5 mg Tablets exporter from India
Venlafaxine ER 37.5 mg tablets exporter
Venlafaxine 37.5 mg tablets supplier India
Venlaf ER 37.5 mg pharmaceutical exporter
Venlafaxine extended release tablets supplier
Venlafaxine 37.5 mg medicine exporter
Venlaf ER tablets wholesale supplier India
Venlafaxine ER 37.5 mg wholesale exporter
Venlafaxine tablets manufacturer supplier India
Venlafaxine 37.5 mg export supplier
Buy Venlaf ER 37.5 mg tablets wholesale
Venlafaxine 37.5 mg tablets international supplier
Venlafaxine ER medicine supplier from Nagpur India
Premium Venlafaxine 37.5 mg tablets exporter
Trusted pharmaceutical exporter India
Venlafaxine medicine exporter to USA
Venlafaxine medicine exporter to UK
Venlafaxine medicine exporter to Australia
Venlafaxine medicine exporter to Singapore
Venlafaxine medicine exporter to Canada
Venlafaxine medicine exporter to South Korea
Venlafaxine medicine exporter to UAE
Venlaf ER 37.5 mg supplier for international buyers
Venlafaxine extended release pharmaceutical supplier
Venlafaxine 37.5 mg B2B medicine supplier
Venlafaxine tablets bulk export from India
Venlaf ER 37.5 mg wholesale pharmaceutical supplier
Venlafaxine 37.5 mg international pharma exporter
Venlafaxine ER tablets bulk supplier India
Phoenix Exim Venlafaxine pharmaceutical exporter
Keywords







